Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways

American Journal of Pathology

Volumn 162, Issue 3, 2003, Pages 803-814

  Arck, Petra Clara ^a,c   Handjiski, Bori ^a   Peters, Eva Milena J ^a   Peter, Anita S ^a   Hagen, Evelin ^a   Fischer, Axel ^a   Klapp, Burghard F ^a   Paus, Ralf ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; SUBSTANCE P; SUBSTANCE P ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GROWTH INHIBITION; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; INFLAMMATION; MACROPHAGE MIGRATION; MAST CELL; MENTAL STRESS; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 0037370738     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63877-1     Document Type: Article

References (72)

1. Selye H: The Physiology and Pathology of Exposure to Stress. Montreal, ACTA Inc. Medical Publishers, 1950, p 727
2. Trepat L, Petre AJ: 'Pelada Universal por shock emotiva.' Semana Med 1942, 1:65
3. Whitlook FA: Psychophysiological aspects of skin disease. Major Problems in Dermatology, vol 8. Edited by A Rook. London, Saunders, 1976
4. York J, Nicholson T, Minors P, Duncan DF: Stressful life events and loss of hair among adult women, a case-control study. Psychol Rep 1998, 82:1044-1046
5. Garcia-Hernandez MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho F: Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999, 26:625-662
6. Sinclair R: Diffuse hair loss. Int J Dermatol 1999, 38:8-18
7. MacAlpine I: Is alopecia areata psychosomatic? A psychiatric study. Br J Dermatol 1958, 70:117-131
8. Van der Steen P, Boezeman J, Duller P, Happle R: Can alopecia areata be triggered by emotional stress? An unconttolled evaluation of 178 patients with extensive hair loss. Acta Dermatol Venereol 1992, 72:279-280
9. Russiello F, Arciero G, Decaminada F, Corona R, Ferrigno L, Fucci M, Pasquini M, Pasquini P: Stress, attachment and skin disease: a casecontrol study. J Eur Acad Dermatol Venereol 1995, 5:234-239
10. Chrousos GP: Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann NY Acad Sci 1998, 851:311-335
11. Paus R, Cotsarelis G: The biology of hair follicles. N Engl J Med 1999, 341:491-497
12. Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R: Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001, 5:2536-2538
13. Chase HB: Physical factors which influence the growth of hair. The Biology of Hair Growth. Edited by W Montagna, RA Ellis. New York, Academic Press, 1953, pp 435-440
14. Maurer M, Handjiski B, Paus R: Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. AM J Pathol 1997, 150:1433-1441
15. Stenn KS, Paus R: Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494
16. Clark DA, Banwatt D, Chaouat G: Stress-triggered abortion in mice prevented by alloimmunization. Am J Reprod Immunol 1993, 29:141-147
17. Aoki E, Shibasaki T, Kawana S: Intermittent foot shock stress prolongs the telogen stage in the hair cycle of mice. Exp Dermatol, in press
18. Daly TJ: Alopecia areata has low plasma levels of the vasodilator/immunomodulator calcitonin gene-related peptide. Arch Dermatol 1998, 134:1164-1165
19. Paus R, Heinzelmann T, Schultz KD, Furkert J, Fechner K, Czarnetzki BM: Hair growth induction by substance P. Lab Invest 1994, 71:134-140
20. Peters EM, Botchkarev VA, Botchkareva NV, Tobin DJ, Paus R: Haircycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol 2001, 116:236-245
21. von Euler US, Gaddum JH: An unidentified depressor substance in certain tissue extracts. J Physiol 1931, 72:74-87
22. Rathsack R, Oehme P, Roske I, Hilse H: Substance P-like immunoreactivity in plasma and adrenal medulla of rats with spontaneous hypertension and WKY rats under acute stress. Biomed Biochim Acta 1983, 42:955-958
23. Arck PC, Merali FS, Stanisz AM, Stead RH, Chaouat G, Manuel J, Clark DA: Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua. Biol Reprod 1995, 53:814-819
24. Zhu GF, Chancellor-Freeland C, Berman AS, Kage R, Leeman SE, Beller DI, Black PH: Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages. J Neurosci 1996, 16:3745-3752
25. Vaupel R, Jarry H, Schlomer HT, Wuttke W: Differential response of substance P-containing subtypes of adrenomedullary cells to different stressors. Endocrinology 1998, 23:2140-2145
26. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI: Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998, 392:390-394
27. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F, Hunt SP: Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998, 392:394-397
28. Teichberg VI, Cohen S, Blumberg S: Distinct classes of substance P receptors revealed by a comparison of the activities of substance P and some of its segments. Regul Pept 1981, 1:327-333
29. Lee C-M, Iversen LL, Hanley MR, Sandberg BEB: The possible existence of multiple receptors for substance P. Naunyn-Schmiedeberg's Arch Pharmacol 1982, 318:281-287
30. Buck SH, Burcher E: The tachykinins: a family of peptides with a brood of receptors. Trends Pharmacol Sci 1986, 7:65-68
31. Nakanishi S: Mammalian tachykinin receptors. Annu Rev Neurosci 1991, 14:123-136
32. Gether U, Johansen TE, Snider RM, Lowe AJ, Nakanishi S, Schwartz TW: Different binding epitope for substance P and the non-peptide antagonist, CP-96, 345, on the NK1 receptor. Nature 1993, 362:345-348
33. Folkers K, Hörig J, Rosell S, Björkroth U: Chemical design of antagonists of substance P. Acta Physiol Scand 1981, 111:505-506
34. Wang ZY, Tung SR, Strichartz GR, Håkanson R: Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist. Br J Pharmacol 1994, 111:1342-1346
35. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel JF, Blanchard JC, Laduron PM: Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc Natl Acad Sci 1991, 88:10208-10212
36. Snider RM, Constantine JW, Lowe III JA, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW: A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 1991, 251:435-437
37. Betancur C, Azzi M, Rostėne W: Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Physiol Sci 1997, 18:372-386
38. Müller-Röver S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, Stenn KS, Paus R: A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001, 117:3-15
39. Maurer M, Paus R, Czarnetzki BM: Mast cells as modulators of hair follicle cycling. Exp Dermatol 1995, 4:266-271
40. Eichmüller S, van der Veen C, Moll I, Hermes B, Hofmann U, Müller-Röver S, Paus R: Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem 1998, 46:361-370
41. Handjiski BK, Eichmuller S, Hofmann U, Czarnetzki BM, Paus R: Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol 1994, 131:303-310
42. Ljungberg A, Johansson O: Methodological aspects on immunohistochemistry in dermatology with special reference to neuronal markers. Histochem J 1993, 25:735-745
43. Botchkarev VA, Eichmüller S, Johansson O, Paus R: Hair cycledependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol 1997, 386:379-395
44. Botchkarev VA, Eichmuller S, Peters EM, Pietsch P, Johansson O, Maurer M, Paus R: A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle-dependent changes in mast cell-nerve fiber contacts in murine skin. Arch Dermatol Res 1997, 289:292-302
45. Paus R, Peters EM, Eichmüller S, Botchkarev VA: Neural mechanisms of hair growth control. J Invest Dermatol Symp Proc 1997, 2:61-68
46. Peters EM, Botchkarev VA, Botchkareva NV, Tobin DJ, Paus R: Haircycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides. J Invest Dermatol 2001, 116:236-245
47. Paus R, Maurer M, Slominski A, Czarnetzki BM: Mast cell involvement in murine hair growth. Dev Biol 1994, 163:230-240
48. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R: Analysis of apoptosis during hair follicle regression. Am J Pathol 1997, 151:1601-1617
49. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM: Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell 1989, 57:201-209
50. Lavker RM, Miller S, Wilson C, Cotsarelis G, Wei ZG, Yang JS, Sun TT: Hair follicle stem cells: their location, role in hair cycle, and involvement in skin tumor formation. J Invest Dermatol 1993, 101:16S-26S
51. Bienenstock J, Denburg J, Scicchitano R, Stead R, Perdue M, Stanisz A: Role of neuropeptides, nerves and mast cells in intestinal immunity and physiology. Monogr Allergy 1988, 24:134-143
52. Williams RH, Bienenstock J, Stead RH: Mast cells - the neuroimmune connection. Chem Immunol 1995, 61:208-251
53. Theoharides TC, Singh LK, Boucher W, Pang X, Letoumeau R, Webster E, Chrousos G: Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 1998, 139:403-413
54. Raffa RB: Possible role(s) of neurokinins in CNS development and neurodegenerative or other disorders. Neurosci Biobehav Rev 1998, 22:789-813
55. Hokfelt T, Pernow B, Wahren J: Substance P: a pioneer amongst neuropeptides. J Intern Med 2001, 249:27-40
56. Grelot L, Dapzol J, Esteve E, Frugiere A, Bianchi AL, Sheldrick RL, Gardner CJ, Ward P: Potent inhibition of both the acute and delayed emetic responses to cisplatin in piglets treated with GR205171, a novel highly selective tachykinin NK1 receptor antagonist. Br J Pharmacol 1998, 124:1643-1650
57. Fukuda H, Koga T, Furukawa N, Nakamura E, Shiroshita Y: The tachykinin NK1 receptor antagonist GR205171 prevents vagal stimulation-induced retching but not neuronal transmission from emetic vagal afferents to solitary nucleus neurons in dogs. Brain Res 1998, 802:221-231
58. Onuoha GN, Alper EK, Chukwulobelu R, Nicholls DP: Distributions of VIP, substance P, neurokinin A and neurotensin in rat heart: an immunocytochemical study. Neuropeptides 1999, 33:19-25
59. Agro A, Stanisz AM: Neuroimmunomodulation classical and nonclassical cellular activation. Adv Neuroimmunol 1995, 5:311-319
60. Singh VK: Neuropeptides as native immune modulators. Prog Drug Res 1995, 45:9-31
61. McGillis JP, Mitsuhashi M, Payan DG: Immunomodulation by tachykinin neuropeptides. Ann NY Acad Sci 1990, 594:85-94
62. Rupniak NM, Kramer MS: Discovery of the antidepressant and antiemetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 1999, 20:485-490
63. Spehner V, De Wazieres B, Nicod L, Harraga S, Robert JF, Seilles E: Auditory stress induces changes in membrane functions of mouse peritoneal macrophages. Scand J Immunol 1996, 44:643-647
64. Ohlemiller KK, Wright JS, Heidbreder AF: Vulnerability to noise-induced hearing loss in 'middle-aged' and young adult mice: a doseresponse approach in CBA, C57BL, and BALB inbred strains. Hear Res 2000, 149:239-247
65. Panteleyev AA, Jahoda CA, Christiano CA: Hair follicle predetermination. J Cell Sci 2001, 114:3419-3431
66. Yeh WC, Hakem R, Woo M, Mak TW: Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling. Immunol Rev 1999, 169:283-302
67. Totpal K, Singh S, Lapushin R, Aggarwal BB: Qualitative and quantitative differences in the cellular responses mediated through Fas antigen and tumor necrosis factor. J Interferon Cytokine Res 1996, 16:259-267
68. Manna SK, Mukhopadhyay A, Aggarwal BB: IFN-α suppresses activation of nuclear transcription factors NF-κB and activator protein 1 and potentiates TNF-induced apoptosis. J Immunol 2000, 165:4927-4934
69. Ruckert R, Lindner G, Bulfone-Paus S, Paus R: High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol 2000, 143:1036-1039
70. Wilson C, Cotsarelis G, Wei ZG, Fryer E, Margolis-Fryer J, Ostead M, Tokarek R, Sun TT, Lavker RM: Cells within the bulge region of mouse hair follicle transiently proliferate during early anagen: heterogeneity and functional differences of various hair cycles. Differentiation 1994, 55:127-136
71. Paus R: Stress and the skin. Exp Dermatol 2001, 10:367
72. Williamson D, Gonzalez M, Finlay AY: The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2000, 15:137-139